List of Publicly Traded Pet and Veterinary Companies Listed on Major U.S. Exchanges

The publicly traded pet industry can broadly be divided into five segments: pet food and nutrition, pet supplies and accessories, veterinary diagnostics and healthcare, pet pharmaceuticals and pharmacies, and pet insurance. Each segment carries a different risk and growth profile. Pharmaceutical and diagnostic companies tend to be more defensive, while premium food and insurance names can be more growth-oriented and volatile.

The pet industry is widely categorized as recession-resilient rather than truly recession-proof. Essential categories such as veterinary care, pet food, and medication tend to hold up well because pet owners treat these as non-negotiable expenses. However, discretionary pet spending on luxury accessories, premium services, and elective procedures is sensitive to broader consumer confidence and disposable income. During elevated inflationary periods, some consumers shift to private-label pet products or delay non-urgent veterinary visits.

PetSmart was previously a publicly traded company but was acquired by a private equity consortium in early 2015 for approximately $8.7 billion, taking it off public markets. Petco has had an on-again, off-again relationship with public markets. While it did re-list in late 2020 under ticker WOOF, it has since faced significant financial challenges. Neither company is currently an accessible publicly traded investment for retail investors in the standard sense.

PAWZ is an exchange-traded fund managed by ProShares that tracks the FactSet Pet Care Index, offering diversified exposure to publicly traded companies in the pet care sector across food, health, insurance, and retail. It includes both large-cap names like Zoetis (ZTS) and IDEXX Laboratories (IDXX) as well as smaller companies. It can serve as a benchmark for investors evaluating individual pet stock performance, or as a diversified alternative to single-stock selection in this sector.

Micro-cap pet stocks carry elevated risks compared to their large-cap peers, primarily due to thin trading volumes, limited analyst coverage, less institutional oversight, and concentrated revenue exposure to single product lines or geographies. Several micro-cap names on this page have international manufacturing exposure such as China-based operations, introducing additional currency, regulatory, and geopolitical risk. These characteristics can result in high short-term price volatility and may not be suitable for risk-averse investors.

Pet insurance penetration in the U.S. remains significantly lower than in European markets, giving companies like Trupanion (TRUP) a long runway for subscriber growth. The investment thesis for pet insurance stocks typically centers on rising veterinary costs which incentivize insurance adoption, growing pet ownership, and strong customer retention once enrolled. The key risk is claim cost inflation. If veterinary costs rise faster than premium pricing, underwriting margins compress, which can weigh heavily on profitability.

InvestSnips provides a dedicated Pet and Veterinary Industry Comparison Widget that displays trend data, earnings per share (EPS), P/E ratio, and beta for each company on this list. Clicking any company link on this page will also take you to that company's individual page, which includes charts, news links, and access to company website and social media data.

The U.S. pet industry is projected to reach approximately $165 billion in total annual spending in 2026, according to industry research estimates. This represents a year-over-year growth rate of around 4.4%, with long-term CAGR projections of roughly 6.6% through 2031. The industry encompasses food, supplies, veterinary care, services like grooming and boarding, pharmaceuticals, and insurance. While growth has moderated from the pandemic-era surge of 2021-2022, structural tailwinds including aging pet populations and increased health spending per pet remain in place.